Penserra Capital Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-9,091
Closed -$505K – 1133
2025
Q3
$505K Buy
+9,091
New +$487K 0.01% 575
2025
Q1
– Sell
-403
Closed -$29K – 1159
2024
Q4
$29K Buy
+403
New +$29.6K ﹤0.01% 988
2024
Q1
– Sell
-720
Closed -$55K – 1420
2023
Q4
$55K Sell
720
-150
-17% -$9.88K ﹤0.01% 985
2023
Q3
$59K Sell
870
-145
-14% -$11.5K ﹤0.01% 974
2023
Q2
$82K Buy
+1,015
New +$81.6K ﹤0.01% 973
2021
Q4
– Sell
-4,500
Closed -$545K – 1548
2021
Q3
$545K Sell
4,500
-1,540
-25% -$187K 0.01% 476
2021
Q2
$679K Buy
+6,040
New +$636K 0.01% 446
2017
Q1
– Sell
-840
Closed -$21K – 811
2016
Q4
$21K Buy
840
+140
+20% +$3.68K ﹤0.01% 604
2016
Q3
$19K Buy
700
+280
+67% +$7.69K ﹤0.01% 538
2016
Q2
$12K Buy
420
+152
+57% +$3.91K ﹤0.01% 554
2016
Q1
$6K Sell
268
-4
-1% -$88 ﹤0.01% 745
2015
Q4
$6K Buy
+272
New +$6.2K ﹤0.01% 744

Other funds holding TECH

Penserra Capital Management's TECH Position: Q4 2025 in Review

Penserra Capital Management sold out of Bio-Techne (TECH) in Q4 2025, closing a stake of 9,091 shares — an estimated $505K sold.

Penserra Capital Management first reported a position in TECH in Q4 2015 and held it in 12 quarters. The position peaked at $679K in Q2 2021. 586 funds tracked by Wall St. Rank hold TECH as of Q4 2025.

  • Penserra Capital Management reported no remaining Bio-Techne position as of Q4 2025 after selling out during the quarter.
  • Penserra Capital Management sold 9,091 Bio-Techne shares in Q4 2025, an estimated $505K.
  • Penserra Capital Management first reported a position in Bio-Techne in Q4 2015 and held it in 12 quarters.
  • Penserra Capital Management's Bio-Techne position peaked at $679K in Q2 2021.
  • 586 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2025.

Based on Penserra Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.